AUSPEX PHARMACEUTICALS INC's ticker is ASPX and the CUSIP is 05211J102.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $446,112,000 | +188.2% | 4,449,103 | +50.9% | 14.45% | +159.9% |
Q4 2014 | $154,769,000 | +140.0% | 2,949,103 | +17.4% | 5.56% | +136.5% |
Q3 2014 | $64,487,000 | +45.9% | 2,512,160 | +26.6% | 2.35% | +32.3% |
Q2 2014 | $44,185,000 | -27.8% | 1,984,038 | -0.2% | 1.78% | -28.9% |
Q1 2014 | $61,181,000 | – | 1,988,990 | – | 2.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 152,002 | $3,902,000 | 3.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,512,160 | $64,487,000 | 2.35% |
Iguana Healthcare Management, LLC | 90,000 | $2,310,000 | 1.23% |
WALL STREET ASSOCIATES | 435,000 | $11,166,000 | 1.15% |
KNOTT DAVID M | 128,500 | $3,298,595,000 | 0.63% |
Cormorant Asset Management, LP | 100,000 | $2,567,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 165,074 | $4,237,000 | 0.52% |
Granite Point Capital Management, L.P. | 40,000 | $1,027,000 | 0.51% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 423,879 | $10,872,000 | 0.49% |
Perceptive Advisors | 100,000 | $2,567,000 | 0.28% |